| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $204.6M | — | +1.6% |
| Cost of Revenue | $27.7M | — | -9.9% |
| Gross Profit | $176.9M | — | +3.7% |
| R&D Expense | $25.8M | — | -7.1% |
| SG&A Expense | $152.2M | — | +5.5% |
| Operating Income | -$1.1M | — | +24.7% |
| Pre-tax Income | $2.4M | — | -42.4% |
| Income Tax | $13.7M | — | +1073.2% |
| Net Income | -$11.3M | — | -477.5% |
| EPS (Basic) | -$0.39 | — | -490.0% |
| EPS (Diluted) | -$0.39 | — | -490.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $98.9M | -5.6% | +83.6% |
| Short-term Investments | $184.9M | -9.1% | -41.4% |
| Accounts Receivable | $105.1M | -12.2% | +13.5% |
| Inventory | $166.2M | +14.4% | +66.7% |
| Current Assets | $566.8M | -2.9% | -0.9% |
| Total Assets | $911.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $12.8M | — | +291.7% |
| Capital Expenditures | $9.7M | — | +15.7% |
| Investing Cash Flow | -$11.2M | — | -624.3% |
| Financing Cash Flow | -$7.5M | — | +91.5% |
| Free Cash Flow | $3.1M | — | +120.7% |
| +24.7% |
| Current Liabilities | $89.4M | -6.9% | +40.9% |
| Total Liabilities | $119.0M | -5.6% | +25.2% |
| Stockholders' Equity | $792.3M | +1.4% | +24.6% |